Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07548164 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer

StatusRecruiting
PhasePhase 3
Started2026-04-16
View on ClinicalTrials.gov ↗

Amendment history

2026-06-15
Study Status, Eligibility v2
Eligibility criteria+96 characters
[...] 4+3) cancer with all pattern 4 found only in the MRI target; systematic biopsy pattern 4 that is concordant with MRI target per investigator is permissible Gland size ≤ 80 cc Prostate MRI < rT3b disease IPSS < 20 No [...]
2026-05-06
Study Status, Study Description, Eligibility v1
Re-verified, no change to tracked fields
2026-04-17
Original filing
In this study the investigators will find out whether the use of a new type of boost approach called irreversible electroporation (IRE) is as effective as the standard boost approach of radiation therapy for participants with intermediate-risk prostate cancer receiving standard stereotactic body radiotherapy (SBRT).
Trial Details
NCT Number NCT07548164
Lead Sponsor Memorial Sloan Kettering Cancer Center
Collaborators: Angiodynamics, Inc.
Conditions Prostate Cancer
Enrollment 224 participants
Start Date 2026-04-16
Primary Completion 2029-04-16 (estimated)
Study Completion 2029-04-16 (estimated)
Updated on ClinicalTrials.gov 2026-09-18